Allergy Asthma Immunol Res.  2012 Jul;4(4):171-177. 10.4168/aair.2012.4.4.171.

Recent Developments in United Airways Disease

• Ciprandi G
• Caimmi D
• Miraglia del Giudice M
• La Rosa M
• Salpietro
• Marseglia

• KMID: 1970704
• DOI: http://doi.org/10.4168/aair.2012.4.4.171

Abstract

The nose and lung are both part of the respiratory tract. Often the diseases affecting the nose and/or the bronchi are treated separately. However, in recent years, numerous studies have highlighted the fact that the respiratory system is a single entity and the concept of "united airway disease" has become more and more important. The unity of the respiratory tract is confirmed both from a morphological and from a functional point of view. Nevertheless, this concept is also confirmed for the respiratory immune system, innervation and vascularization interesting all along the tract, from the nose to the bronchioles. When treating rhinitis, it is often necessary to assess the presence of asthma. Patients with sinusitis should be evaluated for a possible concomitant asthma. Conversely, patients with asthma should always be evaluated for possible nasal disease. The medications that treat nasal diseases appear to be useful in improving control of asthma and in reducing bronchial hyperresponsiveness as well. Physicians should always keep these notions in mind, and evaluate and treat respiratory diseases taking into account the unity of the respiratory tract.

Keyword

Airways; allergic rhinitis; ARIA; asthma; rhinosinusitis; united airways

MeSH Terms

Asthma
Bronchi
Bronchioles
Humans
Immune System
Lung
Nose
Nose Diseases
Respiratory System
Rhinitis
Rhinitis, Allergic, Perennial
Sinusitis

Reference

1. Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol. 2001. 1:7–13.

2. Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group. World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001. 108:S147–S334.

3. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998. 351:1225–1232.

4. Compalati E, Ridolo E, Passalacqua G, Braido F, Villa E, Canonica GW. The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol. 2010. 6:413–423.

5. Undem BJ, McAlexander M, Hunter DD. Neurobiology of the upper and lower airways. Allergy. 1999. 54:Suppl 57. 81–93.

6. Sluder G. Asthma as a nasal reflex. JAMA. 1919. 73:589–591.

7. Pedersen PA, Weeke ER. Asthma and allergic rhinitis in the same patients. Allergy. 1983. 38:25–29.

8. Crimi E, Milanese M, Oddera S, Mereu C, Rossi GA, Riccio A, Canonica GW, Brusasco V. Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol. 2001. 91:1029–1034.

9. Denburg J. The nose, the lung and the bone marrow in allergic inflammation. Allergy. 1999. 54:Suppl 57. 73–80.

10. Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, Denburg JA. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest. 1997. 100:2466–2475.

11. Gaspar Elsas MI, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol. 1997. 17:404–413.

12. Blaiss MS. Rhinitis-asthma connection: epidemiologic and pathophysiologic basis. Allergy Asthma Proc. 2005. 26:35–40.

13. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000. 161:2051–2057.

14. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001. 107:469–476.

15. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy. 2003. 58:691–706.

16. Mygind N, Bisgaard H. Mygind N, Pipkorn U, Dahl R, editors. Applied anatomy of the airways. Rhinitis and asthma: similarities and differences. 1990. Copenhagen: Munksgaard;21–37.

17. Blanton PL, Biggs NL. Eighteen hundred years of controversy: the paranasal sinuses. Am J Anat. 1969. 124:135–147.

18. Baroody FM. Naclerio RM, Durham SR, Mygind N, editors. Anatomy and physiology. Rhinitis: mechanisms and management. 1999. New York: Dekker;15–27.

19. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, Holgate ST. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995. 310:1225–1229.

20. Buist AS. Risk factors for COPD. Eur Respir Rev. 1996. 6:253–258.

21. Kauffmann F, Neukirch F, Annesi I, Korobaeff M, Doré MF, Lellouch J. Relation of perceived nasal and bronchial hyperresponsiveness to FEV1, basophil counts, and methacholine response. Thorax. 1988. 43:456–461.

22. Davison AG, Fayers PM, Taylor AJ, Venables KM, Darbyshire J, Pickering CA, Chettle DR, Franklin D, Guthrie CJ, Scott MC, Holden H, Wright AL, Gompertz D. Cadmium fume inhalation and emphysema. Lancet. 1988. 1:663–667.

23. Jörres R, Nowak D, Magnussen H. The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med. 1996. 153:56–64.

24. Platts-Mills TA. The role of allergens in allergic airway disease. J Allergy Clin Immunol. 1998. 101:S364–S366.

25. Michel FB, Marty JP, Quet L, Cour P. Penetration of inhaled pollen into the respiratory tract. Am Rev Respir Dis. 1977. 115:609–616.

26. Fontanari P, Zattara-Hartmann MC, Burnet H, Jammes Y. Nasal eupnoeic inhalation of cold, dry air increases airway resistance in asthmatic patients. Eur Respir J. 1997. 10:2250–2254.

27. Saetta M, Maestrelli P, Di Stefano A, De Marzo N, Milani GF, Pivirotto F, Mapp CE, Fabbri LM. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis. 1992. 145:169–174.

28. Togias A. Mechanisms of nose-lung interaction. Allergy. 1999. 54:Suppl 57. 94–105.

29. Corren J. Allergic rhinitis: treating the adult. J Allergy Clin Immunol. 2000. 105:S610–S615.

30. Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, Allaf B. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006. 117:158–162.

31. Barbi E, Longo G. Chronic and recurrent cough, sinusitis and asthma. Much ado about nothing. Pediatr Allergy Immunol. 2007. 18:Suppl 18. 22–24.

32. Tosca MA, Riccio AM, Marseglia GL, Caligo G, Pallestrini E, Ameli F, Mira E, Castelnuovo P, Pagella F, Ricci A, Ciprandi G, Canonica GW. Nasal endoscopy in asthmatic children: assessment of rhinosinusitis and adenoiditis incidence, correlations with cytology and microbiology. Clin Exp Allergy. 2001. 31:609–615.

33. Staikūnienė J, Vaitkus S, Japertienė LM, Ryškienė S. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical an radiological features, allergy and inflammation markers. Medicina (Kaunas). 2008. 44:257–265.

34. Simons FE. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999. 104:534–540.

35. Braman SS, Barrows AA, DeCotiis BA, Settipane GA, Corrao WM. Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest. 1987. 91:671–674.

36. Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol. 1996. 97:1252–1263.

37. Ciprandi G, Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol. 2006. 118:1105–1109.

38. Kapsali T, Horowitz E, Togias A. Rhinitis is ubiquitous in allergic asthmatics. J Allergy Clin Immunol. 1997. 99:S138.

39. Alvarez MJ, Olaguibel JM, García BE, Rodríquez A, Tabar AI, Urbiola E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy. 2000. 55:355–362.

40. Ciprandi G, Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, Tosca M. Role of FEF25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol. 2006. 20:641–647.

41. Valero A, Pereira C, Loureiro C, Martínez-Cócera C, Murio C, Rico P, Palomino R, Dávila I. Interrelationship between skin sensitization, rhinitis, and asthma in patients with allergic rhinitis: a study of Spain and Portugal. J Investig Allergol Clin Immunol. 2009. 19:167–172.

42. Rachelefsky GS, Goldberg M, Katz RM, Boris G, Gyepes MT, Shapiro MJ, Mickey MR, Finegold SM, Siegel SC. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol. 1978. 61:310–314.

43. Annesi-Maesano I. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthmatics. Allergy. 1999. 54:Suppl 57. 7–13.

44. Peroni DG, Piacentini GL, Ceravolo R, Boner AL. Difficult asthma: possible association with rhinosinusitis. Pediatr Allergy Immunol. 2007. 18:Suppl 18. 25–27.

45. Meltzer EO, Szwarcberg J, Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. J Manag Care Pharm. 2004. 10:310–317.

46. Steinke JW. The relationship between rhinosinusitis and asthma sinusitis. Curr Allergy Asthma Rep. 2006. 6:495–501.

47. Jani AL, Hamilos DL. Current thinking on the relationship between rhinosinusitis and asthma. J Asthma. 2005. 42:1–7.

48. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, Bousquet J, Chanez P. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001. 107:73–80.

49. ten Brinke A, Grootendorst DC, Schmidt JT, De Bruïne FT, van Buchem MA, Sterk PJ, Rabe KF, Bel EH. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002. 109:621–626.

50. Durham SR. Effect of intranasal corticosteroid treatment on asthma in children and adults. Allergy. 1999. 54:Suppl 57. 124–131.

51. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002. 109:57–62.

52. Stelmach R, do Patrocínio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005. 128:3140–3147.

53. Mygind N, Bisgaard H, Dahl R. Simultaneous treatment of rhinitis and asthma by nasal inhalation of corticosteroid from a spacer. Allergy. 1999. 54:Suppl 57. 132–135.

54. Shaikh WA. Exhaling a budesonide inhaler through the nose results in a significant reduction in dose requirement of budesonide nasal spray in patients having asthma with rhinitis. J Investig Allergol Clin Immunol. 1999. 9:45–49.

55. Baena-Cagnani CE, Berger WE, DuBuske LM, Gurné SE, Stryszak P, Lorber R, Danzig M. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol. 2003. 130:307–313.

56. Pasquali M, Baiardini I, Rogkakou A, Riccio AM, Gamalero C, Descalzi D, Folli C, Passalacqua G, Canonica GW. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy. 2006. 36:1161–1167.

57. Ciprandi G, Ricca V, Tosca M, Landi M, Passalacqua G, Canonica GW. Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. Allergy. 1999. 54:358–365.

58. Ciprandi G, Tosca M, Passalacqua G, Canonica GW. Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy. Ann Allergy Asthma Immunol. 2001. 87:222–226.

59. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med. 2004. 116:338–344.

60. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy. 2001. 31:616–624.

61. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004. 114:851–857.

62. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Norberg LA, Valovirta E, Wahn U, Möller C. The PAT investigator group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007. 62:943–948.

63. Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'Byrne P, Sheffer A. GINA guidelines on asthma and beyond. Allergy. 2007. 62:102–112.

64. Dixon AE. Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med. 2009. 15:19–24.

65. Ciprandi G, Tosca MA, Castellazzi AM, Cairello F, Salpietro C, Arrigo T, Miraglia Del Giudice M. FEF(25-75) might be a predictive factor for bronchial inflammation and bronchial hyperreactivity in adolescents with allergic rhinitis. Int J Immunopathol Pharmacol. 2011. 24:17–20.

66. Ciprandi G, Brambilla I, Tosca MA, Arrigo T, Salpietro A, Leonardi S, La Rosa M, Marseglia GL. Body mass index is related with bronchial function and reversibility in children with allergic rhinitis and asthma. Int J Immunopathol Pharmacol. 2011. 24:21–24.

67. Marseglia GL, Merli P, Caimmi D, Licari A, Labó E, Marseglia A, Ciprandi G, La Rosa M. Nasal disease and asthma. Int J Immunopathol Pharmacol. 2011. 24:7–12.

68. Miraglia Del Giudice M, Marseglia GL, Leonardi S, Tosca MA, Marseglia A, Perrone L, Ciprandi G. Fractional exhaled nitric oxide measurements in rhinitis and asthma in children. Int J Immunopathol Pharmacol. 2011. 24:29–32.